DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 886 filers reported holding DANAHER CORPORATION in Q4 2013. The put-call ratio across all filers is 0.40 and the average weighting 0.5%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $642,331 | +4.6% | 2,589 | +1.2% | 0.09% | +8.9% |
Q2 2023 | $614,160 | -2.1% | 2,559 | +2.8% | 0.08% | -2.5% |
Q1 2023 | $627,580 | +93568.7% | 2,490 | -1.3% | 0.08% | -8.0% |
Q4 2022 | $670 | -99.9% | 2,523 | +0.2% | 0.09% | -3.3% |
Q3 2022 | $651,000 | +11.5% | 2,519 | +9.4% | 0.09% | +21.3% |
Q2 2022 | $584,000 | -22.6% | 2,303 | -10.6% | 0.08% | -10.7% |
Q1 2022 | $755,000 | -10.1% | 2,575 | +0.9% | 0.08% | -4.5% |
Q4 2021 | $840,000 | +9.8% | 2,552 | +1.5% | 0.09% | +2.3% |
Q3 2021 | $765,000 | +3.9% | 2,514 | -8.3% | 0.09% | +4.9% |
Q2 2021 | $736,000 | +25.8% | 2,742 | +5.4% | 0.08% | +22.4% |
Q1 2021 | $585,000 | +4.1% | 2,601 | +2.8% | 0.07% | -2.9% |
Q4 2020 | $562,000 | +21.6% | 2,530 | +17.8% | 0.07% | +1.5% |
Q3 2020 | $462,000 | +28.3% | 2,147 | +5.5% | 0.07% | +21.4% |
Q2 2020 | $360,000 | +36.4% | 2,035 | +6.9% | 0.06% | +12.0% |
Q1 2020 | $264,000 | +3.5% | 1,904 | +14.6% | 0.05% | +28.2% |
Q4 2019 | $255,000 | +13.3% | 1,662 | +6.5% | 0.04% | +8.3% |
Q3 2019 | $225,000 | +23.0% | 1,560 | +12.6% | 0.04% | +20.0% |
Q1 2019 | $183,000 | +28.0% | 1,385 | 0.0% | 0.03% | +15.4% |
Q4 2018 | $143,000 | -10.1% | 1,385 | -5.4% | 0.03% | +4.0% |
Q3 2018 | $159,000 | +8.2% | 1,464 | -1.6% | 0.02% | +4.2% |
Q2 2018 | $147,000 | +0.7% | 1,488 | 0.0% | 0.02% | 0.0% |
Q1 2018 | $146,000 | +9.0% | 1,488 | +3.1% | 0.02% | +20.0% |
Q4 2017 | $134,000 | +8.1% | 1,443 | 0.0% | 0.02% | 0.0% |
Q3 2017 | $124,000 | +195.2% | 1,443 | +189.8% | 0.02% | +122.2% |
Q2 2017 | $42,000 | -2.3% | 498 | 0.0% | 0.01% | -10.0% |
Q1 2017 | $43,000 | +19.4% | 498 | +8.0% | 0.01% | +66.7% |
Q4 2016 | $36,000 | -33.3% | 461 | -33.0% | 0.01% | -40.0% |
Q3 2016 | $54,000 | -98.5% | 688 | -98.0% | 0.01% | -98.5% |
Q2 2016 | $3,546,000 | +5.2% | 35,106 | -1.2% | 0.69% | +5.5% |
Q1 2016 | $3,371,000 | +29.5% | 35,533 | +26.8% | 0.65% | +18.1% |
Q4 2015 | $2,604,000 | +7.6% | 28,032 | -1.3% | 0.55% | +6.2% |
Q3 2015 | $2,420,000 | +8.3% | 28,404 | +8.8% | 0.52% | +24.8% |
Q2 2015 | $2,235,000 | +4.0% | 26,116 | +3.2% | 0.42% | +29.2% |
Q1 2015 | $2,149,000 | +2970.0% | 25,312 | +2979.3% | 0.32% | +2827.3% |
Q4 2014 | $70,000 | -60.7% | 822 | -65.0% | 0.01% | -62.1% |
Q3 2014 | $178,000 | -3.8% | 2,349 | 0.0% | 0.03% | 0.0% |
Q2 2014 | $185,000 | +198.4% | 2,349 | +185.8% | 0.03% | +163.6% |
Q1 2014 | $62,000 | -27.1% | 822 | -25.1% | 0.01% | -26.7% |
Q4 2013 | $85,000 | +11.8% | 1,097 | 0.0% | 0.02% | +7.1% |
Q3 2013 | $76,000 | +347.1% | 1,097 | +298.9% | 0.01% | +366.7% |
Q2 2013 | $17,000 | – | 275 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Ace Management Global Ltd. | 168,488 | $42,096,727 | 12.36% |
Zeno Equity Partners LLP | 182,612 | $45,660,122 | 12.15% |
Defender Capital, LLC. | 135,187 | $33,776,567 | 11.54% |
Bancreek Capital Management, LP | 56,267 | $14,058,310 | 10.98% |
ARTHUR M. COHEN & ASSOCIATES, LLC | 214,830 | $53,664,407 | 9.84% |
CADEN CAPITAL PARTNERS, LP | 104,501 | $26,109,575 | 9.44% |
Dorsey Asset Management | 306,420 | $76,559,037 | 9.12% |
Consulta Ltd | 500,000 | $124,925,000 | 8.51% |
BOONE CAPITAL MANAGEMENT LLC | 106,360 | $26,574,046 | 6.93% |
Manchester Global Management (UK) Ltd | 150,688 | $37,649,397 | 6.62% |